Alireza Naseri
Abstract
Introduction: To date, there is no accurate information on whether the history of radiotherapy for breast cancer can lead to increased nausea and vomiting in upper limb orthopedic surgery, so we decided to compare the present study with the aim of comparing nausea. And vomiting after upper limb orthopedic ...
Read More
Introduction: To date, there is no accurate information on whether the history of radiotherapy for breast cancer can lead to increased nausea and vomiting in upper limb orthopedic surgery, so we decided to compare the present study with the aim of comparing nausea. And vomiting after upper limb orthopedic surgery in two groups with and without a history of breast radiotherapy. Methods: A total of 90 patients (45 with a history of radiotherapy - 45 healthy) during the years 1399-99 who were candidates for upper limb orthopedic surgery were included in the study by available sampling method and after surgery for nausea And vomiting were compared using the Rhodes Index tool. The collected data were compared using Shaprovillek test and t-test with the significance of P value less than 0.05. Results: The prevalence of nausea and vomiting after upper limb orthopedic surgery in 100% of people with a history of breast radiotherapy and in people without a history of radiotherapy, the prevalence of nausea and vomiting was 40% (18 people) (P = 0.001). The standard deviation ± mean of the total score of nausea and vomiting after surgery in the group of patients with a history of 25.5 ± 5.29 radiotherapy was significantly higher than the group of healthy individuals (14.19 ± 3.45) (P = 0.003). ). Conclusion: History of breast radiotherapy can lead to exacerbation and increase in the number of nausea and vomiting after upper limb orthopedic surgery.
Knee
Alireza Naseri; Abbasali Dehghani; Mohammad Reza Moharrami
Abstract
Introduction: Deep vein thrombosis (DVT) is accompanied by adverse effects after surgery and the prevalence of this complication is unknown following knee replacement surgery in patients with a history of chemotherapy. Therefore, the present study aimed to investigate the frequency of DVT after knee ...
Read More
Introduction: Deep vein thrombosis (DVT) is accompanied by adverse effects after surgery and the prevalence of this complication is unknown following knee replacement surgery in patients with a history of chemotherapy. Therefore, the present study aimed to investigate the frequency of DVT after knee replacement surgery in patients with a history of chemotherapy.Methods: This descriptive-analytical study was performed on 189 candidates for knee replacement surgery who had a history of chemotherapy during 36 months ending in March 2016 and referred to Shohada and Imam Reza hospitals affiliated to Tabriz University of Medical Sciences, Tabriz, Iran. After surgery, patients were evaluated for the incidence of DVT and the factors, influecing it based on the instrument of determining DVT and Doppler ultrasound. Statistical analysis was completed by Spearman’s correlation and regression tests.Results: The mean standard deviation of DVT score was 43.49 ± 6.66, which indicates that after knee replacement surgery, patients with a history of chemotherapy are at high risk for DVT. The prevalence of DVT was 25.92% (N=49) and the number of chemotherapy sessions (P=0.001) correlated with the occurrence of DVT.Conclusion: The prevalence of DVT following knee replacement surgery in people with a history of chemotherapy is above the normal mean reported in the literature. Consequently, further therapeutic and preventive measures are required.
